He, K.; Xu, S.; Shen, L.; Chen, X.; Xia, Q.; Qian, Y.
Ruxolitinib as Adjunctive Therapy for Hemophagocytic LymPhohistiocytosis after Liver Transplantation: A Case Report and Literature Review. J. Clin. Med. 2022, 11, 6308.
https://doi.org/10.3390/jcm11216308
AMA Style
He K, Xu S, Shen L, Chen X, Xia Q, Qian Y.
Ruxolitinib as Adjunctive Therapy for Hemophagocytic LymPhohistiocytosis after Liver Transplantation: A Case Report and Literature Review. Journal of Clinical Medicine. 2022; 11(21):6308.
https://doi.org/10.3390/jcm11216308
Chicago/Turabian Style
He, Kang, Shanshan Xu, Lijing Shen, Xiaosong Chen, Qiang Xia, and Yongbing Qian.
2022. "Ruxolitinib as Adjunctive Therapy for Hemophagocytic LymPhohistiocytosis after Liver Transplantation: A Case Report and Literature Review" Journal of Clinical Medicine 11, no. 21: 6308.
https://doi.org/10.3390/jcm11216308
APA Style
He, K., Xu, S., Shen, L., Chen, X., Xia, Q., & Qian, Y.
(2022). Ruxolitinib as Adjunctive Therapy for Hemophagocytic LymPhohistiocytosis after Liver Transplantation: A Case Report and Literature Review. Journal of Clinical Medicine, 11(21), 6308.
https://doi.org/10.3390/jcm11216308